An ependymoma is a rare tumor that begins in the central nervous system, which comprises the brain and spinal cord. Ependymoma cancer is anaplastic if the cancer cells grow rapidly and are unusual in ...
The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. Anaplastic thyroid cancer is a rare thyroid malignancy; disease-specific mortality ...
Breast implant–associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type of T-cell lymphoma that arises around breast implants. The optimal management of this disease has not been established ...
Because of the volatile history of breast implants, a balanced reference point should be provided to allow patients to understand the new information and avoid the tendency for panic. With respect to ...
Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. The studies were reported simultaneously ...
Please provide your email address to receive an email when new articles are posted on . “Anaplastic thyroid cancer patients with prior histories of other cancers have similar survival outcomes as ...
Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. During the last few years, the application of CD30 monoclonal antibodies has led to the ...
Non-Hodgkin lymphomas of the breast are rare, encompassing approximately 0.04–0.5% of all malignant breast tumors, and the vast majority are B-cell lymphomas. In contrast, lymphomas of T-cell ...
Please provide your email address to receive an email when new articles are posted on . Patients with aggressive thyroid cancer pathology with tracheal and lymphovascular invasion need careful ...
Sixteen institutions across Europe collaborated together to show for the first time that a semi-quantitative anaplastic lymphoma kinase protein expression test, immunohistochemistry, is reliable ...
Nine deaths from a rare form of cancer have been linked to breast implants, the Food and Drug Administration announced Tuesday. Red flags were raised in 2011 regarding the safety of breast implants ...